NFKB1 and Autoimmunity: By driving the inflammatory milieu in both autoimmunity and hypersensitivity, NF-κB activation in macrophages is central to the dysregulation of immune homeostasis and the pathophysiology of these conditions, highlighting its potential as a therapeutic target to modulate immune responses.